Welsh, Carson, Anderson & Stowe Commits $250M to Kiniciti Platform for Cell & Gene Therapy Ecosystem

Welsh, Carson, Anderson & Stowe Acquires Majority Stake in GovernmentCIO

November 2, 2020

IT Services

Welsh, Carson, Anderson & Stowe (WCAS) completed a strategic majority investment in GovernmentCIO, a provider of technology and digital solutions to the federal health IT market. The investment will fund organic growth and support a buy-and-build strategy to expand GovernmentCIO’s capabilities and customer footprint across federal health and adjacent federal IT markets.

Welsh, Carson, Anderson & Stowe Invests in Constitution Surgery Alliance

June 16, 2025

Healthcare Services

Welsh, Carson, Anderson & Stowe (WCAS) has made a strategic growth investment in Constitution Surgery Alliance (CSA), an independent developer and operator of ambulatory surgery centers. The investment will provide capital and healthcare scaling expertise to help CSA expand nationally; CSA currently manages 16 facilities across five states and performs over 100,000 procedures annually.

Welsh, Carson, Anderson & Stowe Makes Strategic Growth Investment in ImageTrend, Inc.

February 10, 2023

Software

Welsh, Carson, Anderson & Stowe (WCAS) made an equity growth investment in ImageTrend, Inc., a market-leading provider of public safety and healthcare software, to accelerate growth and product innovation. WCAS partners with ImageTrend’s management and will add investment team members to the board to support continued expansion of the company’s software, analytics, and services across EMS, hospitals, fire, and public safety end markets.

Welsh, Carson, Anderson & Stowe Acquires TrueCommerce from Accel-KKR

November 11, 2020

Cloud & SaaS

Welsh, Carson, Anderson & Stowe (WCAS) has agreed to acquire a majority stake in TrueCommerce, a global provider of trading partner connectivity and integration solutions, from Accel-KKR. WCAS will partner with TrueCommerce management to drive organic growth and pursue a focused acquisition strategy to expand capabilities and enter new customer segments and geographies; Accel-KKR will retain a minority stake post-close.

Welsh, Carson, Anderson & Stowe and Hg Combine MMIT and Evaluate to Form Global Pharma Commercial Intelligence Provider

August 20, 2021

Data & Analytics

Welsh, Carson, Anderson & Stowe (WCAS) and Hg have combined Yardley, Pennsylvania-based MMIT and London-based Evaluate into a single, PE-controlled pharmaceutical commercial intelligence business. The merger brings together MMIT’s market-access data and Evaluate’s forecasting and commercial analytics to create a $1.6 billion global provider offering end-to-end insights across the drug life cycle; WCAS and Hg will share joint control of the combined company.

Welsh, Carson, Anderson & Stowe and Walgreen Co. Invest in Shields Health Solutions

July 31, 2019

Healthcare Services

Welsh, Carson, Anderson & Stowe (WCAS) and Walgreen Co. (Walgreens) made undisclosed equity investments in Shields Health Solutions to support the company’s national expansion and growth of its integrated specialty pharmacy model. The capital will help Shields expand into new disease states and enhance integrated service and technology offerings while accelerating partnerships with health systems nationwide.